Max Healthcare Institute Ltd (IN:MAXHEALTH)
:MAXHEALTH
Top Page
Max Healthcare Institute Ltd
(MAXHEALTH)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹1,030.00
▼(-14.33% Downside)
Action:ReiteratedDate:11/01/25
Max Healthcare Institute Ltd shows strong financial performance with consistent revenue growth and profitability, which is a significant positive factor. However, the high P/E ratio and low dividend yield suggest the stock may be overvalued, impacting its attractiveness. Technical indicators show a lack of strong momentum, contributing to a moderate overall score.
Positive Factors
Sustained revenue growth
High mid-20s revenue growth reflects durable demand for hospital services and successful capacity or utilization expansion. Over 2-6 months this supports stronger cash flows, better fixed-cost absorption and investment capacity, underpinning sustainable top-line momentum as the network scales.
Negative Factors
Rising total debt trend
Although current leverage is moderate, the documented increase in total debt could erode flexibility if capital spending or interest costs accelerate. Over several months this raises refinancing and covenant risk, limiting ability to fund growth or absorb shocks without raising costs.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained revenue growth
High mid-20s revenue growth reflects durable demand for hospital services and successful capacity or utilization expansion. Over 2-6 months this supports stronger cash flows, better fixed-cost absorption and investment capacity, underpinning sustainable top-line momentum as the network scales.
Read all positive factors
Max Healthcare Institute Ltd (MAXHEALTH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹928.43B
Dividend Yield0.14%
Average Volume (3M)80.22K
Price to Earnings (P/E)84.5
Beta (1Y)1.24
Revenue Growth32.17%
EPS Growth28.12%
CountryIN
Employees19,500
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)3.09
Shares Outstanding973,192,500
10 Day Avg. Volume58,776
30 Day Avg. Volume80,220
Financial Highlights & Ratios
PEG Ratio59.54
Price to Book (P/B)11.29
Price to Sales (P/S)15.07
P/FCF Ratio214.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,243.33Price Target Upside3.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)21.03
Revenue Forecast (FY)₹123.94B
Max Healthcare Institute Ltd Business Overview & Revenue Model
Company Description
Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, k...
How the Company Makes Money
Max Healthcare primarily makes money by delivering medical services through its hospitals and associated care facilities. Key revenue streams typically include: (1) Inpatient services (hospital admissions), where revenue is driven by bed occupancy...
Max Healthcare Institute Ltd Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.41B | 70.28B | 54.06B | 45.63B | 39.37B | 25.08B |
| Gross Profit | 52.71B | 43.77B | 33.53B | 28.31B | 21.89B | 12.76B |
| EBITDA | 20.81B | 18.31B | 14.82B | 12.23B | 9.47B | 3.90B |
| Net Income | 13.57B | 10.76B | 10.58B | 11.04B | 6.05B | -1.38B |
Balance Sheet | ||||||
| Total Assets | 162.81B | 152.14B | 120.00B | 101.02B | 91.89B | 85.44B |
| Cash, Cash Equivalents and Short-Term Investments | 5.73B | 6.82B | 9.80B | 13.74B | 4.81B | 6.27B |
| Total Debt | 32.75B | 30.10B | 13.05B | 6.89B | 11.33B | 13.25B |
| Total Liabilities | 62.29B | 58.34B | 35.92B | 26.92B | 29.07B | 29.06B |
| Stockholders Equity | 100.52B | 93.81B | 84.08B | 74.10B | 62.82B | 56.39B |
Cash Flow | ||||||
| Free Cash Flow | -413.10M | 4.94B | 3.36B | 8.74B | 1.87B | -5.60M |
| Operating Cash Flow | 8.18B | 14.59B | 11.22B | 12.09B | 7.48B | 1.18B |
| Investing Cash Flow | -9.66B | -16.32B | -12.85B | -11.87B | -7.72B | -730.00M |
| Financing Cash Flow | -353.20M | -1.64B | -2.64B | -2.89B | -2.94B | 1.91B |
Max Healthcare Institute Ltd Technical Analysis
Negative
1202.35
Price Trends
1013.09
Negative
1044.98
Negative
1122.36
Negative
Market Momentum
-23.05
Negative
39.94
Neutral
52.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MAXHEALTH, the sentiment is Negative. The current price of 1202.35 is above the 20-day moving average (MA) of 967.53, above the 50-day MA of 1013.09, and above the 200-day MA of 1122.36, indicating a bearish trend. The MACD of -23.05 indicates Negative momentum. The RSI at 39.94 is Neutral, neither overbought nor oversold. The STOCH value of 52.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MAXHEALTH.
Max Healthcare Institute Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹358.56B | 75.82 | ― | 0.24% | 14.72% | 8.37% | |
66 Neutral | ₹928.43B | 84.46 | ― | 0.14% | 32.17% | 28.12% | |
66 Neutral | ₹1.08T | 50.39 | ― | 0.27% | 13.66% | 41.32% | |
65 Neutral | ₹265.51B | 114.01 | ― | ― | 25.74% | 1.41% | |
65 Neutral | ₹286.32B | 83.79 | ― | 0.04% | 15.78% | 15.01% | |
61 Neutral | ₹639.79B | 86.12 | ― | 0.11% | 15.33% | 54.62% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:MAXHEALTH
Max Healthcare Institute Ltd
954.00
-119.21
-11.11%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
7,514.70
760.13
11.25%
IN:FORTIS
Fortis Healthcare Ltd.
847.45
178.94
26.77%
IN:KIMS
Krishna Institute of Medical Sciences Limited
663.55
32.60
5.17%
IN:MEDANTA
Global Health Limited
1,065.20
-210.19
-16.48%
IN:NH
Narayana Hrudayalaya Ltd.
1,754.55
20.28
1.17%
Max Healthcare Institute Ltd Corporate Events
Max Healthcare launches e-voting postal ballot for director re-appointment
Apr 12, 2026
Max Healthcare Institute Ltd has notified stock exchanges that it has published a postal ballot notice in national and regional newspapers and has completed dispatch of the notice to eligible shareholders via email. The move underscores the compan...
Max Healthcare reports no demat requests, confirms fully dematerialized share base
Apr 7, 2026
Max Healthcare Institute Ltd has disclosed that its registrar and share transfer agent, MUFG Intime India Private Limited, confirmed there were no requests for dematerialization of shares during the quarter ended March 31, 2026. The company also r...
Max Healthcare Closes Trading Window Ahead of FY26 Results
Mar 26, 2026
Max Healthcare Institute Ltd has announced the closure of its trading window for all designated persons and their immediate relatives from April 1, 2026, until 48 hours after the declaration of its financial results for the fourth quarter and full...
Max Healthcare Subsidiary ET Planners Dissolved After Voluntary Liquidation
Mar 25, 2026
Max Healthcare Institute Ltd has disclosed that its step-down wholly owned subsidiary, ET Planners Private Limited, has been dissolved following an order by the National Company Law Tribunal’s New Delhi Bench under the voluntary liquidation ...
Max Healthcare to Engage Investors at J.P. Morgan India Forum 2026 in Singapore
Mar 2, 2026
Max Healthcare Institute Ltd has announced that its Chairman and Managing Director will participate in the J. P. Morgan India Forum 2026, an investor conference to be held physically at the Fullerton Hotel in Singapore on March 9 and 10, 2026. The...
Max Healthcare Posts Audio Recording of Q3 FY26 Earnings Call Online
Feb 6, 2026
Max Healthcare Institute Limited has notified the stock exchanges that the audio recording of its earnings call held on February 6, 2026, discussing the company’s financial results for the quarter and nine months ended December 31, 2025, has...
Max Healthcare Publishes Unaudited Q3 and Nine-Month FY2025 Results
Feb 6, 2026
Max Healthcare Institute Limited has announced that its Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, at a meeting held on February 5, 2026. In line...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.